These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15507276)

  • 1. Anticoagulant therapy for the thrombotic complications of the antiphospholipid antibody syndrome.
    Crowther MA
    Thromb Res; 2004; 114(5-6):443-6. PubMed ID: 15507276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence based treatment of the antiphospholipid syndrome II. Optimal anticoagulant therapy for thrombosis.
    Crowther MA; Wisloff F
    Thromb Res; 2005; 115(1-2):3-8. PubMed ID: 15567446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid antibodies in critical illness.
    Dentali F; Crowther M
    Crit Care Med; 2010 Feb; 38(2 Suppl):S51-6. PubMed ID: 20083914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current management of antiphospholipid syndrome-related thrombosis.
    Puente D; Pombo G; Forastiero R
    Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1551-8. PubMed ID: 19954317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thrombosis in the antiphospholipid syndrome.
    Farmer-Boatwright MK; Roubey RA
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):321-5. PubMed ID: 19228605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of antiphospholipid antibody syndrome: a systematic review.
    Lim W; Crowther MA; Eikelboom JW
    JAMA; 2006 Mar; 295(9):1050-7. PubMed ID: 16507806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How much warfarin is enough in APS related thrombosis?
    Erkan D; Lockshin MD
    Thromb Res; 2004; 114(5-6):435-42. PubMed ID: 15507275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipid antibodies and venous thromboembolism.
    Ginsberg JS; Wells PS; Brill-Edwards P; Donovan D; Moffatt K; Johnston M; Stevens P; Hirsh J
    Blood; 1995 Nov; 86(10):3685-91. PubMed ID: 7579334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of anticoagulant therapy after initial idiopathic venous thromboembolism.
    Frazee LA; Chomo DL
    Ann Pharmacother; 2003 Oct; 37(10):1489-96. PubMed ID: 14519045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of thrombosis associated with immunological risk factors.
    Valesini G; Pittoni V
    Ann Med; 2000 Dec; 32 Suppl 1():41-5. PubMed ID: 11209981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longterm anticoagulation is preferable for patients with antiphospholipid antibody syndrome. result of a decision analysis.
    Brunner HI; Chan WS; Ginsberg JS; Feldman BM
    J Rheumatol; 2002 Mar; 29(3):490-501. PubMed ID: 11908562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for venous thromboembolism in children.
    Gerotziafas GT
    Int Angiol; 2004 Sep; 23(3):195-205. PubMed ID: 15765033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular events in patients with antiphospholipid antibodies: strategies of prevention.
    Tufano A; Guida A; Di Minno MN; De Gregorio AM; Cerbone AM; Di Minno G
    Nutr Metab Cardiovasc Dis; 2010 May; 20(4):217-23. PubMed ID: 20153613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C; Mouret P
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiphospholipid antibiodies: a critical review of the literature.
    Lim W; Crowther MA
    Curr Opin Hematol; 2007 Sep; 14(5):494-9. PubMed ID: 17934356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolism: risk factors for recurrence.
    Zhu T; Martinez I; Emmerich J
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid syndrome.
    Erkan D; Lockshin MD
    Curr Opin Rheumatol; 2006 May; 18(3):242-8. PubMed ID: 16582686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of antiphospholipid syndrome.
    Tuthill JI; Khamashta MA
    J Autoimmun; 2009 Sep; 33(2):92-8. PubMed ID: 19559568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low intensity warfarin: is it clinically useful in venous thromboembolism management?
    Bauer KA
    Br J Haematol; 2004 Oct; 127(2):155-8. PubMed ID: 15461620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral anticoagulant therapy in subjects with congenital or acquired thrombophilia.
    Baglin T
    Semin Vasc Med; 2003 Aug; 3(3):315-22. PubMed ID: 15199465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.